Public ILADS Webinar in December
https://mailchi.mp/ilads.org/upcoming-webinar-with-dr-tom-moorcroft-
|
|||||
|
|||||
|
Archive for the ‘Uncategorized’ Category
Case Report of Male With Anaplasmosis
Relative Bradycardia in a 61-Year-Old Male With Anaplasmosis: A Case Report
Published: October 17, 2025
DOI: 10.7759/cureus.94785
Cite this article as: James J A, Brown M, Segal S M, et al. (October 17, 2025) Relative Bradycardia in a 61-Year-Old Male With Anaplasmosis: A Case Report. Cureus 17(10): e94785. doi:10.7759/cureus.94785
Abstract
Human granulocytic anaplasmosis (HGA), or anaplasmosis, is a tick-borne illness caused by Anaplasma phagocytophilum, a gram-negative intracellular bacterium. A. phagocytophilum is primarily transmitted by Ixodes scapularis in the northeast United States and by Ixodes pacificus in California. Presenting symptoms typically include fever, chills, malaise, headache, myalgia, and rarely a rash. This case describes a 61-year-old Black male with a complex medical history, including prior tick-borne and arboviral infections (Lyme disease, dengue fever, and chikungunya), hypertension, mixed hyperlipidemia, bilateral carotid artery dissection, gastroesophageal reflux disease, atrial fibrillation with rapid ventricular response, and current tobacco use. This patient presented to an emergency department in upstate New York with a fever, fatigue, constipation, myalgia, and night sweats. Throughout the patient’s hospital course, he maintained a state of relative bradycardia. The patient reported that he had returned from Haiti and the Dominican Republic two weeks prior to presentation in the emergency department and received several mosquito bites while abroad. Initial guideline-based empiric treatment was started with doxycycline due to suspicion of tick-borne illness, given his history of Lyme disease and his onset of symptoms while in upstate New York. Treatment was continued to complete a 14-day course after confirming the diagnosis of anaplasmosis by PCR testing of whole blood. After completing treatment with doxycycline, the patient’s symptoms resolved completely. This case illustrates a unique finding of relative bradycardia and fever of unknown origin in the context of recent international travel and history of tick-borne and arboviral infections.
How Microbes Like Lyme May Trigger Alzheimer’s & Cognitive Decline
http:// Approx. 15 Min
- https://madisonarealymesupportgroup.com/2024/10/22/kris-kristoffersons-shocking-tale-of-lyme-induced-alzheimers/
- https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/
- https://madisonarealymesupportgroup.com/2022/09/19/ahead-of-the-curve-interview-with-dr-alan-mcdonald/
- https://madisonarealymesupportgroup.com/2018/10/03/chronology-of-research-on-lyme-disease-dementia-alzheimers-parkinsons-autism/
- https://madisonarealymesupportgroup.com/2019/03/09/researchers-identify-herpes-1-chlamydia-pneumoniae-several-types-of-spirochaete-as-major-causes-of-alzheimers/
- https://madisonarealymesupportgroup.com/2017/01/18/a-bug-for-alzheimers/
- https://madisonarealymesupportgroup.com/2016/08/09/dr-paul-duray-research-fellowship-foundation-some-great-research-being-done-on-lyme-disease/
- https://madisonarealymesupportgroup.com/2021/11/22/could-an-80-year-old-drug-cure-alzheimers-disease/
- https://madisonarealymesupportgroup.com/2025/10/15/ivermectins-accidental-breakthrough-parkinsons-alzheimers/
More Original Independent Research Presented at CHEST 2025 Than Presented by Many Major Institutions
https://imahealth.substack.com/p/ima-at-chest-2025-a-milestone-in?
IMA at CHEST 2025: A Milestone in Independent Medical Research
At CHEST 2025, IMA presented more original research than many major institutions. With over 1,600 peer-reviewed publications between Drs. Varon and Marik, independent science is gaining ground.
CHEST has long been a stronghold of institutional medicine: an annual gathering where pulmonary and critical care physicians from the world’s largest hospital systems and academic centers set the tone for clinical standards and scientific recognition.
At CHEST 2025, something different happened: an independent alliance is outpacing the establishment.
Led by IMA President Dr. Joseph Varon, our team contributed more original research than many of the most well-funded organizations in the country. That isn’t a boast; it’s a measurable step forward in reclaiming scientific spaces that were once closed to independent researchers.
“At CHEST 2025, I was struck by the fact that the IMA—our independent, grassroots organization—had more scientific presentations than some of the largest medical institutions in the country. Proof that dedication and vision often outperform size and bureaucracy.” — Dr. Joseph Varon
What is CHEST and Why Does It Matter
Founded in 1935, the CHEST Annual Meeting is organized by the American College of Chest Physicians. It is one of the most influential global conferences in pulmonary, critical care, and sleep medicine. Each year, thousands of clinicians, researchers, and policymakers gather to share emerging science, update protocols, and shape future guidelines.
Participation at CHEST is a strong signal of credibility. It’s the place where clinical science is discussed not just in theory, but in terms of its immediate application to patient care. For an independent medical group to be not only present but prominent shows that change in medicine is possible—and already underway.
Independent, Evidence-Driven, and Growing
For decades, CHEST has been the domain of large academic institutions and government-aligned research groups. This year, Dr. Varon, together with several of his researchers and students, presented a dozen original abstracts, including work on:
-
Pulmonary disease
-
Intensive care medicine
-
Optimization of patient care
That kind of presence doesn’t happen by accident. It’s the result of years of persistence, especially at a time when independent research was under immense pressure.
If you followed us during the COVID era, you’ll know that our physicians challenged flawed policies and raised concerns about mRNA vaccine harms. The response was swift: licenses were threatened, voices were censored, and reputations attacked. But the work continued.
The fact that we’re here today—publishing, presenting, and helping shape clinical conversations—is a testament to the strength of our mission. We survived a Goliath-like effort to silence us, and we’re still standing. Still researching. Still delivering solutions for patients.
Proof in the Medical Literature
Beyond CHEST, IMA researchers continue to publish in respected peer-reviewed journals. Recent examples include:
These studies are recent examples of a much broader trend: our science, once dismissed, is now being examined seriously. The same mainstream institutions that ignored our findings are beginning to revisit the data and ask questions we have been asking for years.
Our Research Leadership
IMA’s growing influence in medical research reflects leadership grounded in clinical experience, scientific rigor, and long-term commitment.
Dr. Joseph Varon, Co-Founder and Chief Medical Officer of IMA, has authored more than 1,000 peer-reviewed studies while continuing to practice medicine and mentor the next generation of researchers. He also leads the editorial vision of the Journal of Independent Medicine as its Editor-in-Chief, ensuring a continued focus on practical, patient-centered science.
Dr. Paul Marik, Co-Founder and Chief Scientific Officer, has published over 600 peer-reviewed papers and remains one of the most cited intensivists in the world. His recent induction into the Orthomolecular Medicine Hall of Fame recognized both the scope and influence of his scientific contributions.
Together, they’ve helped establish a model for medical research that puts patients first, values real-world outcomes, and refuses to compromise on scientific integrity.
A Journal for Uncensored Science
The Journal of Independent Medicine is preparing to release its fourth edition this November, marking the completion of its inaugural year.
The journal exists for one purpose: to give space to research that asks difficult but essential questions. Many of those questions cannot be raised in pharmaceutical-sponsored publications. Here, they can. It is a platform for physicians and scientists who still believe that medicine must serve patients first and tell the truth, even when it is inconvenient.
Expanding in 2026: Special Editions
Building on the success of its first year, IMA will introduce two new special editions in 2026:
-
“Treating Post-Vaccine Complications”
-
Submission Deadline: December 31, 2025
-
Publication Date: 2026
-
-
“Repurposed Drugs and Nutraceuticals in the Chronic Disease Epidemic”
-
Submission Deadline: February 28, 2026
-
Publication Date: 2026
-
These editions will expand opportunities for independent researchers and clinicians to publish meaningful work that drives progress rather than compliance.
👉 Submit your research or learn more here
Looking Ahead
CHEST 2025 was not about arrival or recognition. It was about progress earned through steady, verifiable work.
Through peer-reviewed research, transparent publishing, and the leadership of dedicated physicians, IMA is proving that independent medicine can thrive within the highest levels of scientific discourse.
Our work has always stood on its own merit. What has changed is that the world is finally ready to recognize it. And this is only the beginning.
For more coverage, check out where our globetrotting team of experts has been lately below:
-
Independent Medical Alliance Advances Health Policy Reform in Washington, D.C.
-
Dr. Paul Marik Inducted into the Orthomolecular Medicine Hall of Fame
-
“Truth Has No Borders”: IMA Senior Fellows Join Global Medical Leaders in Spain
-
Health Freedom on the Line: IMA at the 2025 Reclaiming Conference in Canada
________________
**Comment**
This is wonderful news and another wonderful silver lining to COVID mania.
Independent research has been the only thing moving the Lyme/MSIDS needle, and because it’s such a polarized disease, research is political, not scientific and is purposely designed for a predetermined outcome.
The world is beginning to see what Lymeland has known for over 40 years.
Study Links Surge in Children’s Memory Problems to Radiation Exposure
Study Links Surge in Children’s Memory Problems to Wireless Radiation Exposure
Children and teens in Sweden and Norway are experiencing an “alarming” rise in memory problems, according to the authors of a new peer-reviewed study that linked the issue to increased exposure to wireless radiation. “Radiation exposure must be reduced, and people must be informed about the associated health risks,” one of the study’s authors said.
Children and teens in Sweden and Norway are experiencing an “alarming” rise in memory problems, which the authors of a new peer-reviewed study attributed to increased exposure to wireless radiation.
“The steep increase in memory issues cannot be explained by changes in diagnostic criteria or reporting to the registries alone,” Lennart Hardell, M.D., Ph.D., one of the study’s authors, said in a press release. He added:
“We urge our findings on increasing numbers of children having impaired memory to be taken seriously by public health authorities and consider children’s increasing exposure to wireless radiation as a possible cause.
“Thus, we ask for measures aimed at decreasing exposure to RF radiation [radiofrequency radiation] to protect the brain and general health of children.”
The study was published this month in the Archives of Clinical and Biomedical Research.
Hardell, an oncologist and epidemiologist with the Environment and Cancer Research Foundation, has authored more than 350 papers, nearly 60 of which address RF radiation. He is also one of the first researchers to publish reports on the toxicity of Agent Orange.
Hardell and lead study author Mona Nilsson, co-founder and director of the Swedish Radiation Protection Foundation, examined national health data in Sweden and Norway and found that the number of medical consultations for memory disturbances in Norwegian children ages 5-19 increased roughly 8.5-fold from 2006 to 2024.
In Sweden, the number of children ages 5-19 diagnosed with mild cognitive impairment — a diagnosis that includes memory problems — increased nearly 60-fold from 2010 to 2024.
“The findings must be taken seriously and evaluated,” Hardell told The Defender. “Action must be taken to reduce children’s overall exposure — especially in schools.”
Nilsson agreed. “These alarming trends must be reversed — radiation exposure must be reduced, and people must be informed about the associated health risks,” she said.
Authors link memory problems to wireless radiation
The authors argued in their report that wireless radiation is a leading cause of memory decline in children.
They cited numerous epidemiological and experimental studies showing that very low levels of RF radiation can negatively affect the brain — particularly the hippocampus, which plays a central role in memory and learning.
“There is abundant evidence [dating back] several decades, both on animals and humans, that RF radiation impairs memory,” Nilsson said. “The trends we are observing coincide closely in time with the sharply increasing exposure of children and adolescents to RF radiation.”
Wireless exposure has escalated in the last decade due to the increasing use of cellphones, wireless headsets, Wi-Fi and 5G, Hardell said.
“Other contributing factors can, of course, not be excluded,” he said. “They must, however, be defined and not based on hypothetical discussion.”
New investigation targets ‘biased’ European report on RF radiation
The new study coincides with the European Ombudsman investigation into how the European Commission handled a key report that found no “moderate or strong” evidence linking adverse health effects to chronic or acute RF radiation exposure from existing wireless technologies.
The European Ombudsman, who “investigates complaints about maladministration by EU [European Union] institutions and bodies,” will question the European Commission on how it chose the experts to write the report, said Sophie Pelletier, president of PRIARTEM/Electrosensibles de France, in an Oct. 22 press release.
The report, called the SCHEER Opinion, was adopted in April 2023 by the European Commission’s Scientific Committee on Health, Environmental and Emerging Risks (SCHEER).
The SCHEER Opinion was “clearly biased,” according to an October 2023 critique published by the Council for Safe Telecommunications in Denmark and the Swedish Radiation Protection Foundation.
The investigation stems from a complaint filed by several European nonprofits, including the Swedish Radiation Protection Foundation, alleging that the authors of the SCHEER Opinion had conflicts of interest due to industry ties or industry-funded research.
The nonprofits also claimed that the European Commission excluded experts critical of wireless radiation’s possible health effects from the report’s working group and that the report authors ignored peer-reviewed studies showing harmful effects from exposure below current limits.
In the U.S., the Federal Communications Commission (FCC) has not updated its RF radiation exposure limits since 1996 and bases them largely on a few small sample studies conducted in the 1970s and 1980s.
The FCC has not yet complied with a 2021 court-ordered mandate to explain how it determined that its current guidelines adequately protect humans and the environment from the harmful effects of RF radiation exposure.
Related articles in The Defender
- 5G — The Untold Story’: New Documentary Spotlights Health Hazards of Wireless Radiation
- ‘High Certainty’ Cellphone Radiation Linked to Cancer in Animals, WHO Study Finds
- New Report Adds to Evidence That Cellphone Radiation May Cause Brain Cancer
- Kids Developed Headaches, Stomach Pain, Sleeping Issues While at Vacation Home Near Multiple 5G Antennas
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
________________
**Comment**
Houston, we have a real problem…..
Please also read, “Wired for Harm: The Biological and Spiritual Costs of Wireless Radiation.”
For more:
- https://madisonarealymesupportgroup.com/2025/10/24/new-study-connects-wireless-radiation-oxidative-stress-and-alzheimers-disease/
- https://madisonarealymesupportgroup.com/2020/12/16/radiation-from-wireless-devices-may-cause-breast-cancer-new-study-shows/
- https://madisonarealymesupportgroup.com/2019/12/17/biological-response-to-pulsed-microwave-radiation-from-wireless-communication-systems-implications-for-current-future-exposure-safety-levels/
- https://madisonarealymesupportgroup.com/2025/09/17/maha-report-addresses-emfs-study-shows-high-wireless-emf-exposure-more-than-triples-risk-of-neuro-delays-in-infants/
- https://madisonarealymesupportgroup.com/2025/09/10/aap-hasnt-updated-advice-on-cellphone-radiation-in-nearly-a-decade-att-listed-among-funders/
- https://madisonarealymesupportgroup.com/2024/04/12/chd-files-foia-requests-why-did-government-shut-down-studies-on-cellphone-radiation-cancer/
- https://madisonarealymesupportgroup.com/2025/02/25/study-cell-phones-make-blood-clump-together-just-like-the-clot-shots-do/
- https://madisonarealymesupportgroup.com/2021/09/17/september-is-suicide-prevention-month-cell-phone-wifi-disrupts-blood-brain-barrier-recent-court-victory-fcc-not-protecting-the-public/
- https://madisonarealymesupportgroup.com/2024/02/08/the-importance-of-emf-remediation-in-the-treatment-of-chronic-disease/
- https://madisonarealymesupportgroup.com/2020/09/15/the-dark-side-of-technology-how-to-protect-yourself-from-emfs/
- https://madisonarealymesupportgroup.com/2019/03/13/despite-lack-of-studies-safety-standards-relaxed-ahead-of-5g-emf-health-effects-survey-shows-health-harm-rat-study-shows-microwaves-cause-brain-permeability/
- https://madisonarealymesupportgroup.com/2020/02/25/emf-questions-answered-1/
- https://madisonarealymesupportgroup.com/2019/05/10/free-emf-guide/
Madison Area Lyme Support Group 